Spectral AI, Inc.

Equities

MDAI

US84757T1051

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 17:47:00 08/07/2024 BST 5-day change 1st Jan Change
1.93 USD +0.52% Intraday chart for Spectral AI, Inc. -1.54% -21.95%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Spectral AI Partners With PolyNovo to Deploy Burn Wound Diagnostics System in Australia MT
Spectral AI, Inc. Announces Collaboration with PolyNovo Limited CI
Spectral AI Increases US Sites for Burn Study MT
Spectral AI, Inc. Expands Clinical Trial Sites for Pivotal U.S. Burn Study CI
Spectral Ai Achieves 100% Pediatric Enrollment in Burn Centers for Pivotal U.S. Burn Study CI
Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell Microcap Growth Index CI
Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell 3000E Index CI
Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell Microcap Index CI
Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell 3000E Growth Index CI
Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study CI
Spectral AI, Inc. Appoints Erich Spangenberg as A Director CI
Spectral AI, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : Spectral AI, Inc., Q1 2024 Earnings Call, May 07, 2024
Spectral AI, Inc. Reiterates Revenue Guidance for the Year 2024 CI
Spectral AI, Inc. Appoints Erich Spangenberg CEO of Spectral IP, Its Health Care IP-Focused Subsidiary CI
Spectral AI, Inc. Announces Chief Operating Office Changes CI
Spectral AI, Inc. Announces the Appointment of Jeremiah A. Sparks as Chief Commercialization Officer CI
Spectral AI, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Spectral AI, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Transcript : Spectral AI, Inc., Q4 2023 Earnings Call, Mar 27, 2024
Spectral AI, Inc. announced that it expects to receive $30 million in funding CI
Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of Deepview? Wound Imaging System CI
Spectral AI, Inc. Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem CI
Spectral AI Names Peter Carlson Chief Executive Officer; Reaffirms 2024 Preliminary Revenue Guidance MT
Spectral AI, Inc. Announces Chief Executive Officer Changes CI
Chart Spectral AI, Inc.
More charts
Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid health care providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.92 USD
Average target price
5.867 USD
Spread / Average Target
+205.56%
Consensus
  1. Stock Market
  2. Equities
  3. MDAI Stock
  4. News Spectral AI, Inc.
  5. Spectral AI Increases US Sites for Burn Study